Interview for "CIIPA Annual Report 2022" with Mr. Kuan CHEN, Founder and CEO of Infervision Medical

"Innovative, technological, young and promising"



Infervision, founded in 2016, is an AI medical technology company dedicated to developing AI medical products intended for disease screening and diagnosis, disease intervention and treatment, patient management and medical research, for full-hospital deployment serving physicians from multiple departments. They embrace “Advancing Technology, Inspiring Healthcare” and endeavor to provide more value propositions to the medical community. As a young but leading company, Infervision is one of the few AI medical technology companies in the world with four major market accesses, including FDA, CE, PMDA and NMPA, products cover more than 400 medical institutions in nearly 20 countries worldwide.


It is worth mentioning that in the past two years, the AI solutions offered by Infervision has contributed a lot to the prevention and control of COVID-19.